CN1436857A - Specificity determination and application of one section of candida albicans DNA sequence - Google Patents

Specificity determination and application of one section of candida albicans DNA sequence Download PDF

Info

Publication number
CN1436857A
CN1436857A CN 02113352 CN02113352A CN1436857A CN 1436857 A CN1436857 A CN 1436857A CN 02113352 CN02113352 CN 02113352 CN 02113352 A CN02113352 A CN 02113352A CN 1436857 A CN1436857 A CN 1436857A
Authority
CN
China
Prior art keywords
sequence
candida albicans
section
specificity
dna sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 02113352
Other languages
Chinese (zh)
Inventor
谭德勇
朱宝生
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KUNMING HUANJI BIOCHIP DEVELOPMENT Co Ltd
Original Assignee
KUNMING HUANJI BIOCHIP DEVELOPMENT Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by KUNMING HUANJI BIOCHIP DEVELOPMENT Co Ltd filed Critical KUNMING HUANJI BIOCHIP DEVELOPMENT Co Ltd
Priority to CN 02113352 priority Critical patent/CN1436857A/en
Publication of CN1436857A publication Critical patent/CN1436857A/en
Pending legal-status Critical Current

Links

Images

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The present invention relates to specificity determination and application of one section of candida albicans DNA sequence, and belongs to the field of biomedicine. Through gene data base data search and analysis, the specificity and PCR amplification primer of one section of candida albicans DNA sequence is determined, and the sequence length is 241 bp. By means of PCR amplification and cloning of women's genital tract candida albicans infection sample, the sequence is obtained and sequenced to obtain the result the same as the predicted. Biological informatics and gene chip hybrid analysis proves the specificity of the sequence to candida albicans. The present invention is used as probe and PCR amplification detection sequence for gene chip diagnosis for candida albicans.

Description

The specificity of one section of candida albicans DNA sequence is determined and is used
Technical field:
The specificity that the present invention relates to one section of candida albicans (Candida albicans) dna sequence dna is determined and application, belongs to field of biomedicine technology.
Background technology:
Candida albicans is the pathogen that a kind of woman vagina often infects, and diagnosis accurately is to carry out the foundation of treatment immediately and reliably, can only diagnose according to clinical indication at present.PCR and gene chip diagnosis are a kind of rapid and precise detection methods.And the diagnostic method of this class depends on the special nucleotide sequence of acquisition.
Summary of the invention:
The invention reside in by information biology and Protocols in Molecular Biology, determined one section of candida albicans specific nucleotide sequence and PCR primer thereof.This sequence can be used for setting up gene chip with corresponding PCR primer and PCR method is carried out the diagnosis of Candida albicans.
Technical scheme of the present invention is: the present invention utilizes existing method to determine one section of candida albicans (Candida albicans) specific DNA sequence and the PCR primer thereof of length for 241bp, carries out pcr amplification with primer, and its sequence is as follows:
1?gagaccaact?ggttgggaaa?aacaagattt?acaattataa?tgatttgttt?gtttgtttgc
61?tttatattta?tggtttggta?taagttagat?agtctagttt?gatagtcttg?tttgattgtt
121?tatatatgta?tagatttaat?ggtttgcttt?gttttatgag?tttttttgat?atctggagta
181?gttaaagact?catctttgag?aaataggaga?ccaaacttgt?tgagttacaa?ttgacgtcgc
241?a
Primer sequence is:
1.5’-gagaccaactggttgggaaa-3’
2.5’-tgcgacgtcaattgtaactca-3’
Above-mentioned Candida albicans specific DNA sequence detects sequence as the probe and the pcr amplification of gene chip diagnosis, is used for the clinical diagnosis of Candida albicans.
Description of drawings:
Fig. 1 is the pcr amplification collection of illustrative plates of clinical samples.
Fig. 2, Fig. 2 are continuous to be sequencer map.Wherein Fig. 2 be sequence, Fig. 2 of measuring continuous be the primitive sequencer collection of illustrative plates.
Fig. 3 is with the sequencing result and the comparative analysis of estimating sequence of Blast software to pcr amplification product.
Fig. 4, Fig. 4 continue (1), Fig. 4 continuous (2) is a Blast Search Results in the gene database.
Fig. 5. the gene chip hybridization result.
Embodiment:
Be keyword at first with Candida albicans (Candida albicans), the nucleotide sequence of search Candida albicans in gene database.Obtain the closer nucleotide sequence of several relations altogether, with these nucleotide sequences with the nucleotide sequence (nr) in the online use software of the online Blast of the NCBI comparison gene database, discharge nonspecific nucleotide sequence, obtained the specific nucleotide sequence of 1Kb.With this section sequences Design surplus 20 to the PCR primer, extract DNA with clinical samples, carry out pcr amplification, screen a pair of sequence and the primer that is fit to carry out pcr amplification, the product that pcr amplification obtains with estimate that big or small consistent (see Fig. 1, sequence number is among the figure: 1. standard molecular weight DNA, the molecular weight size is respectively from top to bottom: 622,527,404,309,242/238,217,201,190,180,160+160,147+147,123; 2.4.5 clinical negative sample does not have amplified production; 3. clinical positive sample, amplified production is very pure, and size about 240 is consistent with the expectation size.The collection of illustrative plates result shows with the special amplification clinical sample of the energy of the primer among the present invention), clone with T-vector then, and the order-checking (sequencer address is seen Fig. 2, among the figure since 47, to 287,241bp is a cloned sequence altogether, all the other sequences are the cloning vector sequence), sequence is 241bp, estimates sequence by the comparison of Blast software, shows with the sequence of estimating is consistent and (sees Fig. 3, change over a by g except that the 79th among the figure, all the other are all consistent with the expectation sequence), show that this sequence can be can be used for Candida albicans PCR and detect by specific amplification.Sequence is with DNA (the comprising cDNA) sequence of the Blast muca gene database of NCBI website, this sequence is only consistent with the sequence of Candida albicans, and do not have homology (to see that Fig. 4, Fig. 4 continue (1), Fig. 4 continuous (2) with other species sequence, search result shows among the figure, sequence and this sequence homology of having only Candida albicans (Candida albicans), and being to match fully, the sequence homology of one section about 70bp is arranged, also is the sequence of Candida albicans.And other sequence has only the short sequence about 40 characters, because these sequences do not have primer to match therewith, so can not be detected in detection).With behind this sequence mark as probe with contain the gene chip hybridization of 45 gene locuss of 9 kinds of kinds of genitourinary infection pathogen, have only sequence of the present invention that hybridization signal is arranged therewith, and other all sequences therewith the amixia signal (see Fig. 5, be two repetitions among the figure, each repeats to contain 9 kinds of urogenital infections disease pathogen things totally 60 different sites.Results of hybridization shows to have only this sequence that special signal is arranged, and other equal amixia signal), show that this sequence is the distinguished sequence of Candida albicans.
The present invention can be used for the clinical detection that PCR method or method for gene chip carry out Candida albicans.Carry out pcr amplification with sequence provided by the invention, obtain product according to PCR method and whether occur judging whether to be candida albicans infection with size.An also available sequence is a probe, as a detection site in the gene chip, then with the amplification of the PCR primer sequence among the present invention clinical samples, and hybridizes detection behind the mark.

Claims (2)

1. the specificity of one section of candida albicans DNA sequence is determined, the length that it is characterized in that this sequence is 241bp, and sequence and PCR primer are as follows:
1?gagaccaact?ggttgggaaa?aacaagattt?acaattataa?tgatttgttt?gtttgtttgc
61?tttatattta?tggtttggta?taagttagat?agtctagttt?gatagtcttg?tttgattgtt
121?tatatatgta?tagatttaat?ggtttgcttt?gttttatgag?tttttttgat?atctggagta
181?gttaaagact?catctttgag?aaataggaga?ccaaacttgt?tgagttacaa?ttgacgtcgc
241?a
Primer sequence is:
1.5’-gagaccaactggttgggaaa-3’
2.5’-tgcgacgtcaattgtaactca-3’
2. the application of one section of candida albicans DNA sequence it is characterized in that this sequence is used for the probe of gene chip diagnosis as the distinguished sequence of Candida albicans, and pcr amplification detects sequence.
CN 02113352 2002-02-06 2002-02-06 Specificity determination and application of one section of candida albicans DNA sequence Pending CN1436857A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 02113352 CN1436857A (en) 2002-02-06 2002-02-06 Specificity determination and application of one section of candida albicans DNA sequence

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 02113352 CN1436857A (en) 2002-02-06 2002-02-06 Specificity determination and application of one section of candida albicans DNA sequence

Publications (1)

Publication Number Publication Date
CN1436857A true CN1436857A (en) 2003-08-20

Family

ID=27628420

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 02113352 Pending CN1436857A (en) 2002-02-06 2002-02-06 Specificity determination and application of one section of candida albicans DNA sequence

Country Status (1)

Country Link
CN (1) CN1436857A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1294418C (en) * 2004-08-09 2007-01-10 中国人民解放军南京军区南京总医院 Method and reagent box for inspecting mycelian protein antibody of white candida
CN103882135A (en) * 2014-03-31 2014-06-25 深圳意达凯生物科技有限公司 Primer pair for detecting candida albicans, kit and application thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1294418C (en) * 2004-08-09 2007-01-10 中国人民解放军南京军区南京总医院 Method and reagent box for inspecting mycelian protein antibody of white candida
CN103882135A (en) * 2014-03-31 2014-06-25 深圳意达凯生物科技有限公司 Primer pair for detecting candida albicans, kit and application thereof

Similar Documents

Publication Publication Date Title
CN1436857A (en) Specificity determination and application of one section of candida albicans DNA sequence
CN102071247A (en) Detection method for distinguishing non-pneumophilia legionella and legionella pneumophilia and kit
CN1168833C (en) Determination for specificity of candida albicans DNA sequence (4) and use thereof
CN1168835C (en) Determination for specificity of Candida albicans DNA sequence (2) and use thereof
CN1168834C (en) Determination for specificity of Candida albicans DNA sequence (5) and use thereof
CN1436852A (en) Specificity determination and application of one section of gonococcus DNA sequence
CN1205341C (en) Determination of man-shaped mycoplasma DNA sequence (5) specificity and its use
CN1493698A (en) Determination of one section vagina bacillus Gardner DNA sequence (3) specificity and its application
CN1465708A (en) Determination for specificity of candida albicans DNA sequence (3) and use thereof
CN113667668A (en) HBV detection based on CRISPR/Cas system
CN1238521C (en) Determination of a section of man-shaped mycoplasma DNA sequence (4) specificity and its use
CN1206366C (en) Determination of man-shaped mycoplasma DNA sequence (2) specificity and its use
CN1170945C (en) Determination for specificity of ureaplasma DNA sequence (1) and use thereof
CN1465717A (en) Determination for specificity of one segmentum gonococcus DNA sequence (4) and use thereof
CN1493699A (en) Determination of one section vagina bucillus Gardner DNA sequence (2) specificity and its application
CN1570136A (en) Human type mycoplasma DNA sequence (3) specificity determination and its uses
CN1285734C (en) Determination of one section human type mycoplasmas DNA sequence (1) specificity and its application
CN1206367C (en) Determination of a section of mycoplasma urealyticum DNA sequence (4) specificity and its use
CN1465715A (en) Determination for specificity of one segmentum gonococcus DNA sequence (5) and use thereof
CN1495265A (en) Definition of Gardner's bacillus DNA sequence (1) specificity of vagina and its application
CN1465716A (en) Determination for specificity of one segmentum gonococcus DNA sequence (3) and use thereof
CN1465714A (en) One segmentum gonococcus DNA sequence (2) specificity detemination and use thereof
CN1267564C (en) Determination of one section urea degraded mycoplasmos DNA sequence (5) specificity and its application
CN1495267A (en) Definition of human papillomavirus-6 DNA sequence (4) specificity and its application
CN1495269A (en) Definition of vaginal Gardner's bacillus DNA sequence (4) specificity and its application

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication